Amgen

IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Amgen sues Samsung biotech unit over bone drug copies
Reuters
Tue, 08/13/24 - 11:08 pm
Amgen
Samsung
biologics
biosimilars
legal
Prolia
Xgeva
5 Obesity Readouts to Watch in the Second Half of 2024
BioSpace
Tue, 08/13/24 - 11:47 am
obesity
clinical trials
Novo Nordisk
CagriSema
Amgen
MariTide
Monlunabant
Aphaia Pharma
APHD-012
Terns Pharmaceuticals
TERN-601
Biotech giant Amgen announces new office in tech-savvy Hyderabad
Investment Monitor
Sun, 08/11/24 - 10:39 pm
Amgen
India
Hyderabad
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Medicare
drug pricing
Inflation Reduction Act
Bristol Myers Squibb
Eli Lilly
JNJ
Bayer
Merck
AstraZeneca
Novartis
Amgen
AbbVie
Novo Nordisk
Amgen's marketing efforts help boost Tepezza sales
Fierce Pharma
Wed, 08/7/24 - 11:27 am
Amgen
earnings
Tepezza
Amgen revenue surges 20% to $8.4B while net income dips in Q2
Medical Marketing and Media
Tue, 08/6/24 - 05:55 pm
Amgen
earnings
Amgen’s Imdelltra BiTEs into SCLC treatment drought
Clinical Trials Arena
Sun, 07/14/24 - 10:15 pm
Amgen
Imdelltra
small cell lung cancer
BiTEs
Amgen Axes Development of Early-Stage Bispecific T-Cell Engager for Solid Tumors
BioSpace
Wed, 07/10/24 - 11:11 am
Amgen
T-cell engager
AMG 794
solid tumors
clinical trials
In boost to Amgen, analysts predict osteoporosis market share shift
Fierce Pharma
Fri, 06/28/24 - 11:28 am
Amgen
osteoporosis
Amgen’s Blincyto approved by FDA for new acute lymphoblastic leukaemia indication
PM Live
Mon, 06/17/24 - 10:28 pm
Amgen
FDA
Blincyto
acute lymphoblastic leukemia
Amgen's drug meets main goal in late-stage study for rare disease
Reuters
Wed, 06/5/24 - 11:03 am
Amgen
clinical trials
Uplinza
IgG4-RD
ASCO: Bristol Myers' KRAS confirmatory data avoid Amgen's flaws but leave FDA prospect unclear
Fierce Pharma
Sun, 06/2/24 - 02:51 pm
ASCO 2024
Bristol Myers Squibb
Amgen
KRAS inhibitors
Krazati
non-small cell lung cancer
FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
Reuters
Tue, 05/28/24 - 10:29 pm
Amgen
AstraZeneca
biosimilars
Soliris
Bkemv
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Amgen
AstraZeneca
COPD
Sanofi
Regeneron
Tezspire
Dupixent
In Big Pharma's growth rankings, Lilly took top spot from Novo Nordisk in Q1
Fierce Pharma
Thu, 05/16/24 - 09:51 pm
Big Pharma
Eli Lilly
Novo Nordisk
earnings
Amgen
FDA approves Amgen drug for small cell lung cancer
Reuters
Thu, 05/16/24 - 09:47 pm
Amgen
tarlatamab
FDA
small cell lung cancer
Winners and Losers in Biopharma’s Q1 2024 Earnings Season
BioSpace
Wed, 05/15/24 - 11:30 am
earnings
Amgen
AstraZeneca
Novo Nordisk
Biogen
Bristol Myers Squibb
JNJ
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Amgen's new Horizon products bolster top line despite continued Tepezza struggles
Fierce Pharma
Fri, 05/3/24 - 11:23 am
Amgen
Horizon Pharma
Krystexxa
Tepezza

Pages